gam501
Gene therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2002 (NCT00065663)
Timeline
Indications
Mechanism of action
- Platelet-derived growth factor subunit ASupplementation
PDGFA supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gam501
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00493051 | Phase 2 | Nov 1, 2007 | Gene Biotherapeutics, Inc., Tissue Repair Company |
| NCT00065663 | Phase 1 | Aug 1, 2002 | Tissue Repair Company |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tissue Repair Company | For profit | 2 | 2 | 2 | 2002 |
| Gene Biotherapeutics, Inc. | For profit | 1 | 0 | 1 | 2007 |
2 organizations
Page 1 / 1